Continuing or Discontinuing Low-Dose Aspirin Before Transrectal Prostate Biopsy: Results of a Prospective Randomized Trial

Urology

Volumn 70, Issue 3, 2007, Pages 501-505

  Giannarini, Gianluca ^a   Mogorovich, Andrea ^a   Valent, Francesca ^b   Morelli, Girolamo ^a   De Maria, Maurizio ^a   Manassero, Francesca ^a   Barbone, Fabio ^b   Selli, Cesare ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEMATURIA; HEMOSPERMIA; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SELF EVALUATION; STATISTICAL SIGNIFICANCE; TELECONSULTATION; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ASPIRIN; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HEMOSPERMIA; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OFFICE VISITS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROSTATE; QUESTIONNAIRES; RECTUM;

EID: 34648843839     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.04.016     Document Type: Article

References (14)

1. Djavan B., Waldert M., Zlotta A., et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 166 (2001) 856-860
2. Raaijmakers R., Kirkels W.J., Roobol M.J., et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60 (2002) 826-830
3. Ghani K.R., Dundas D., and Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight-, and 12-core biopsy protocol. BJU Int 94 (2004) 1014-1020
4. Ihezue C.U., Smart J., Dewbury K.C., et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60 (2005) 459-463
5. Smith N.L., Psaty B.M., Furberg C.D., et al. Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch Intern Med 159 (1999) 1574-1578
6. Herget E.J., Saliken J.C., Donnelly B.J., et al. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J 50 (1999) 173-176
7. Connor S.E., and Wingate J.P. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol 54 (1999) 598-603
8. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 136 (2002) 157-160
9. Rodriguez L.V., and Terris M.K. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol 160 (1998) 2115-2120
10. Maan Z., Cutting C.W., Patel U., et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 91 (2003) 798-800
11. Burger W., Chemnitius J.M., Kneissl G.D., et al. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis. J Intern Med 257 (2005) 399-414
12. Lee G., Attar K., Laniado M., et al. Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit. Int Urol Nephrol 38 (2006) 281-285
13. Douketis J.D. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 108 (2003) 3-13
14. Douketis J.D., Johnson J.A., and Turpie A.G. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Arch Intern Med 164 (2004) 1319-1326